Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2018 3
2019 3
2020 12
2021 5
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Heterologous vaccine therapy associated with half course of Miltefosine promote activation of the proinflammatory response with control of splenic parasitism in a hamster model of visceral leishmaniasis.
Carvalho LM, Ferreira FC, Gusmão MR, Costa AFP, de Brito RCF, Aguiar-Soares RDO, Reis AB, Cardoso JMO, Carneiro CM, Roatt BM. Carvalho LM, et al. Curr Res Immunol. 2021 Nov 5;2:194-201. doi: 10.1016/j.crimmu.2021.10.003. eCollection 2021. Curr Res Immunol. 2021. PMID: 35492387 Free PMC article.
Immunochemotherapy for visceral leishmaniasis: combinatorial action of Miltefosine plus LBSapMPL vaccine improves adaptative Th1 immune response with control of splenic parasitism in experimental hamster model.
Carvalho LM, Gusmão MR, Costa AFP, de Brito RCF, Aguiar-Soares RDO, Cardoso JMO, Reis AB, Carneiro CM, Roatt BM. Carvalho LM, et al. Parasitology. 2022 Mar;149(3):371-379. doi: 10.1017/S0031182021001906. Epub 2021 Nov 2. Parasitology. 2022. PMID: 35264268 Free PMC article.
Flau-A, a naphthoquinone derivative, is a promising therapeutic candidate against visceral leishmaniasis: A preliminary study.
Mendonça DVC, Tavares GSV, Pereira IAG, Oliveira-da-Silva JA, Ramos FF, Lage DP, Machado AS, Carvalho LM, Reis TAR, Carvalho AMRS, Ottoni FM, Ludolf F, Freitas CS, Martins VT, Chávez-Fumagalli MA, Duarte MC, Humbert MV, Roatt BM, Menezes-Souza D, Alves RJ, Coelho EAF. Mendonça DVC, et al. Among authors: carvalho lm. Exp Parasitol. 2022 Feb;233:108205. doi: 10.1016/j.exppara.2021.108205. Epub 2021 Dec 28. Exp Parasitol. 2022. PMID: 34968460
Leishmania eukaryotic elongation Factor-1 beta protein is immunogenic and induces parasitological protection in mice against Leishmania infantum infection.
Santos TTO, Machado AS, Ramos FF, Oliveira-da-Silva JA, Lage DP, Tavares GSV, Mendonça DVC, Cardoso MS, Siqueira WF, Martins VT, Ludolf F, Reis TAR, Carvalho LM, Freitas CS, Bandeira RS, Silva AM, Oliveira JS, Moreira RLF, Fujiwara RT, Roatt BM, Chávez-Fumagalli MA, Humbert MV, Teixeira AL, Coelho EAF. Santos TTO, et al. Among authors: carvalho lm. Microb Pathog. 2021 Feb;151:104745. doi: 10.1016/j.micpath.2021.104745. Epub 2021 Jan 21. Microb Pathog. 2021. PMID: 33485994
Corrigendum to "Leishmania infantum pyridoxal kinase evaluated in a recombinant protein and DNA vaccine to protects against visceral leishmaniasis". Molecular Immunology 124 (2020) 161-171.
Oliveira-da-Silva JA, Lage DP, Ramos FF, Machado AS, Tavares GSV, Mendonça DVC, Pereira IAG, Martins VT, Carvalho LM, Ludolf F, Santos TTO, Reis TAR, Freitas CS, Bandeira RS, Silva AM, Costa LE, Oliveira JS, Duarte MC, Roatt BM, Teixeira AL, Coelho EAF. Oliveira-da-Silva JA, et al. Among authors: carvalho lm. Mol Immunol. 2020 Dec;128:55. doi: 10.1016/j.molimm.2020.09.002. Epub 2020 Oct 15. Mol Immunol. 2020. PMID: 33068834 No abstract available.
A Leishmania amastigote-specific hypothetical protein evaluated as recombinant protein plus Th1 adjuvant or DNA plasmid-based vaccine to protect against visceral leishmaniasis.
Oliveira-da-Silva JA, Machado AS, Ramos FF, Tavares GSV, Lage DP, Mendonça DVC, Pereira IAG, Santos TTO, Martins VT, Carvalho LM, Freitas CS, Ludolf F, Reis TAR, Bandeira RS, Silva AM, Costa LE, Oliveira JS, Duarte MC, Roatt BM, Teixeira AL, Coelho EAF. Oliveira-da-Silva JA, et al. Among authors: carvalho lm. Cell Immunol. 2020 Oct;356:104194. doi: 10.1016/j.cellimm.2020.104194. Epub 2020 Aug 13. Cell Immunol. 2020. PMID: 32827943
22 results